Pancreatic Cancer Research

ResearcherColumbia UniversityNo recent work listed

Gloria Huei-Ting Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5158-6019; OpenAlex author ID A5050228874; NIH RePORTER profile ID 1879958. Sources: funder_awards.

Their work

Papers
10 (first author 1, last author 3)
Trials
0
Grants
5
Labs led
2
Collaborators
35
Papers, trials and grants by year

2007: 1 grant · 2008: none · 2009: none · 2010: 1 grant · 2011: none · 2012: 1 paper · 2013: 2 papers · 2014: none · 2015: 1 grant · 2016: none · 2017: none · 2018: none · 2019: 4 papers, 1 grant · 2020: 1 paper · 2021: 2 papers, 1 grant

Papers 10

  1. Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Last author DOI 10.1038/s41388-021-02040-9↗
  2. Dual Roles of the Activin Signaling Pathway in Pancreatic Cancer. Last author DOI 10.3390/biomedicines9070821↗
  3. Identifying Novel Genetic Markers Through a Transcription-Wide Association Study: Can This Be a Path to Reducing the Burden of Pancreatic Cancer? First author DOI 10.1093/jnci/djz247↗
  4. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Last author DOI 10.1016/j.canlet.2018.11.007↗
  5. Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells. Co-author DOI 10.1080/15384047.2019.1579956↗
  6. Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. Co-author DOI 10.1158/1541-7786.mcr-19-0589↗
  7. Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells. Co-author DOI 10.2174/1568009618666180430123939↗
  8. Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Co-author DOI 10.1158/1535-7163.mct-12-1030↗
  9. Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC. Co-author DOI 10.1158/1535-7163.mct-13-0234↗
  10. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. Co-author DOI 10.1007/s11605-011-1754-9↗

Grants 5

  1. The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling R01CA217207↗
  2. The role of wild-type KRAS in the context of tumor profession and metastasis R01CA178445↗
  3. Mouse Model for Human Pancreatic Ductal Adenocarcinoma R01CA109525↗
  4. Notch Decoy Signaling in Pancreatic Cancer Stem Cells AWARD pancan:2010-gloria-su-phd-notch-decoy-signaling-in-pancreatic-canc
  5. Activin Signaling in the Development of Pancreatic Cancer Precursor Lesions AWARD pancan:2007-gloria-huei-ting-su-phd-activin-signaling-in-the-development-of-

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wanglong Qiu · 5 shared papers, 2012–2021 · strength 0.45
  2. Jiayuh Lin · 2 shared papers, 2019 · strength 0.28
  3. Yan Han · 2 shared papers, 2019–2021 · strength 0.20
  4. Yi Miao · 2 shared papers, 2019–2021 · strength 0.20
  5. Regina M. Santella · 1 shared paper, 2020 · strength 0.19
  6. Jeanine M. Genkinger · 1 shared paper, 2020 · strength 0.19
  7. Chunhua Xi · 2 shared papers, 2019 · strength 0.17
  8. Xiang 'Anthony' Chen · 1 shared paper, 2019 · strength 0.14
  9. Ling Ma · 1 shared paper, 2019 · strength 0.14
  10. Haoqiang Ying · 1 shared paper, 2021 · strength 0.11
  11. Ji Luo · 1 shared paper, 2021 · strength 0.11
  12. Yunpeng Peng · 1 shared paper, 2019 · strength 0.09
  13. Jishu Wei · 1 shared paper, 2019 · strength 0.09
  14. Min Tu · 1 shared paper, 2019 · strength 0.09
  15. Aditi Jain · 1 shared paper, 2019 · strength 0.08
  16. Teena Dhir · 1 shared paper, 2019 · strength 0.08
  17. Alex O. Haber · 1 shared paper, 2019 · strength 0.08
  18. Christopher William Schultz · 1 shared paper, 2019 · strength 0.08
  19. Talia Golan · 1 shared paper, 2019 · strength 0.08
  20. Liang Xu · 1 shared paper, 2019 · strength 0.08
  21. Samantha Z. Brown · 1 shared paper, 2019 · strength 0.08
  22. Jonathan Robert Brody · 1 shared paper, 2019 · strength 0.08
  23. James A. Posey · 1 shared paper, 2019 · strength 0.08
  24. Michael Jon Pishvaian · 1 shared paper, 2019 · strength 0.08
  25. Charles J. Yeo · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.